Study to Evaluate Efficacy, Safety, and Tolerability of MT-7117 in Subjects With Diffuse Cutaneous Systemic Sclerosis

PHASE2CompletedINTERVENTIONAL
Enrollment

76

Participants

Timeline

Start Date

February 5, 2021

Primary Completion Date

January 17, 2024

Study Completion Date

February 14, 2024

Conditions
Diffuse Cutaneous Systemic Sclerosis
Interventions
DRUG

MT-7117

MT-7117

DRUG

Placebo

Placebo

Trial Locations (34)

3000

UZ Leuven, Leuven

4000

Centre Hospitalier Universitaire (CHU) de Liege - Domaine Universitaire du Sart Tilman, Liège

9000

Universitair Ziekenhuis Gent, Ghent

20122

Universita degli Studi di Milano - Azienda Ospedaliera Istituto Ortopedico Gaetano Pini, Milan

21218

Johns Hopkins University, Baltimore

28041

Hospital Universitario 12 de Octubre, Madrid

29009

Hospital Regional Universitario de Málaga, Málaga

32174

Millennium Research, Ormond Beach

33024

GNP Research, Hollywood

38119

Shelby Research, LLC, Memphis

44124

University of Ferrara Azienda Ospedaliero-Universitaria Sant' Anna, Cona

60590

CIRI, Centrum fur innovative Diagnostik und Therapie Rheumatologie und Immunologie (GmbH) Am Klinikum der Johann Wolfgang Goethe-Universitat, Frankfurt am Main

72076

University Hospital Of Tuebingen, Tübingen

77030

The University of Texas Medical School at Houston, Houston

85306

Arizona Arthritis, Glendale

90045

Pacific Arthritis Care Center, Los Angeles

91054

Internistisches Zentrum des Universitaetsklinikums Erlangen, Erlangen

94063

The Board of Trustees of the Leland Stanford Junior University, Redwood City

06519

Yale School of Medicine - The Anlyan Center (TAC) for Medical Research & Education, New Haven

02114

Massachusetts General Hospital, Boston

48109-5422

University of Michigan Comprehensive Cancer Center, Ann Arbor

M5T 3L9

Mount Sinai Hospital, The Rebecca Macdonald Centre For Arthritis And Autoimmune Disease, Toronto

15-276

Uniwersytecki Szpital Kliniczny w Bialymstoku, Bialystok

82-300

Centrum Kliniczno-Badawcze J.Brzezicki, B.Gornikiewicz-Brzezicka Lekarze Spolka partnerska, Elblag

30-149

Malopolskie Centrum Kliniczne, Krakow

30-363

Centrum Medyczne Plejady, Krakow

60-218

Medyczne Centrum Hetmanska, Poznan

00-874

Medycyna Kliniczna, Warsaw

52-416

Centrum Medyczne Oporow, Wroclaw

08208

Institut d'Investigacio i Innovacio Parc Tauli, Hospital Universitari Parc Taulí, Sabadell

08003

Hospital Del Mar, Barcelona

08041

Hospital de la Santa Creu i Sant Pau, Barcelona

EH4 2XU

Western General Hospital, Edinburgh

NW3 2QG

The Royal Free Hospital - Royal Free London NHS Foundation Trust, London

All Listed Sponsors
lead

Mitsubishi Tanabe Pharma America Inc.

INDUSTRY